High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$49K
$49,957
Total Sells (Filtered)
$37.7M
$37,723,200
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2026-03-30 | $25,048,725MEGA | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Sell
|
2025-12-15 | $4,994,140Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-15 | $17,291,855MEGA | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Sell
|
2025-12-15 | $12,273,395MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-15 | $28,819,763MEGA | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Other
|
2025-12-15 | $950,430 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Sell
|
2025-12-15 | $20,455,665MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Buy
|
2025-09-18 | $49,957 | P | Form 4 |